Patent litigation at Hahn Loeser means getting the science right, building our legal positions around technically sound arguments and then bringing those arguments to life in the courtroom setting. We have a deep bench of experienced and creative patent litigators with years of courtroom experience in high stakes patent infringement litigation, representing both plaintiffs and defendants.
Experience in Popular Patent Venues
Our attorneys regularly appear in trials, Markman hearings and contentious motion practice, injunctions and appeals in courts across the country, including the U.S. Supreme Court, U.S. Court of Appeals for the Federal Circuit and popular patent venues such as the District of Delaware, Western District of Texas, District of New Jersey, Northern District of Illinois, Northern District of Ohio, Southern District of New York, Northern District of California, and the Eastern District of Michigan and also have appeared before the Judicial Panel on Multidistrict Litigation. We also have experience with ex parte and inter partes proceedings before the U.S. Patent and Trademark Office including advising clients on Inter Partes Review (“IPR”) and Post Grant Review (“PGR”) strategies. We also have experience before the International Trade Commission, U.S. Customs Service, Federal Trade Commission (“FTC”), Food and Drug Administration (“FDA”), and other agencies.
We have one of the most experienced Hatch Waxman/pharmaceutical and life sciences litigation practices in the country, with a proven record of getting our clients’ products to market. We have successfully invalidated patents on a number of major drugs. We have successfully invalidated patents on a number of major drugs, including Norvasc®, Actonel®, and Boniva®. Other cases of note involve Antara®, Abilify® (oral solution), Fosrenol®, Benicar®, Benicar® HCT, Uroxatral®, Eloxatin®, Treanda®, Zometa®, Reclast® and Ultracet® and Levothyroxine Sodium Injection. We also have experience in related FDA and regulatory litigation and counseling directed to obtaining marketing approval for generic drugs, developing unique first filer and subsequent filer strategies.
High Tech, Materials, Biotechnology, Alternative Energy and other Technologies
We have experience litigating a number of other high technology areas including clean coal, biofuels and ethanol processing, UV wastewater treatment, printing and color management solutions, smart phones, digital photography, medical analytic devices, solar cells, semiconductor processing, high brightness LEDs, lighting devices, semiconductor lasers, jet engine and aircraft related parts and systems, automotive parts and embedded control systems, agricultural equipment, truck transmissions, polymeric materials, metals, rare-earth magnets, textiles, antennaes, receivers and transmission devices, computer hard disk drives and brushless direct current motors, source code and call center/e-commerce technology.
Our litigation experience is international in scope, and we have assisted clients in the enforcement and defense of their patent rights in Europe, India and East Asia, Canada and Latin America.
We strive to provide cost certainty while matching the legal spend to the client’s business objectives. The idea is that every dollar the client spends is directed towards driving down the client’s potential exposure, with clearly defined litigation objectives and benchmarks directed to achieving this goal. For example, it makes no sense to spend a million dollars defending a case that can be settled for $2500. In some cases, we have moved away from the billable hour and developed alternative fee agreements that reward efficiency and success.